(Q89239293)
Statements
Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries (English)
V Brodszky
L Gulacsi
O Balogh
P Baji
F Rencz
scientific article published on 26 October 2014